Celldex (CLDX) believes that the cash, cash equivalents and marketable securities at March 31, along with the approximately $323.9M in net proceeds from its April underwritten public offering, are sufficient to meet estimated working capital requirements and fund current planned operations through 2028.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDX: